Publication | Closed Access

Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study

Cancer ImmunosurveillanceMedicineMelanomaImmunologyMelanoma TreatedImmune SurveillanceImmune Checkpoint InhibitorMulticenter Retrospective StudyImmunotherapyOncologyClinical EfficacySkin Cancer